Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
2017/07/19Adocia presents first half 2017 financial results
2017/07/11Number of shares and voting rights of ADOCIA as of June 30, 2017